TD Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,541,044
Closed -$30.2M 1220
2026
Q1
$30.2M Sell
1,541,044
-422,008
-21% -$10.3M 0.02% 423
2025
Q4
$52.6M Buy
1,963,052
+31,160
+2% +$803K 0.04% 310
2025
Q3
$51.5M Sell
1,931,892
-103,038
-5% -$2.66M 0.04% 314
2025
Q2
$46.7M Sell
2,034,930
-177,212
-8% -$4.4M 0.04% 334
2025
Q1
$64.1M Buy
2,212,142
+371,856
+20% +$11.9M 0.06% 270
2024
Q4
$68.3M Sell
1,840,286
-294,752
-14% -$13.5M 0.06% 258
2024
Q3
$103M Buy
2,135,038
+443,469
+26% +$19.5M 0.09% 197
2024
Q2
$67.7M Buy
1,691,569
+680,976
+67% +$28.2M 0.06% 254
2024
Q1
$44.4M Buy
1,010,593
+217,034
+27% +$11.2M 0.04% 323
2023
Q4
$49.1M Buy
793,559
+649,001
+449% +$34.1M 0.05% 294
2023
Q3
$6.65M Sell
144,558
-13,500
-9% -$736K 0.01% 666
2023
Q2
$9.08M Buy
158,058
+151,558
+2,332% +$6.72M 0.01% 619
2023
Q1
$244K Buy
+6,500
New +$213K ﹤0.01% 1363
2022
Q3
Sell
-6,500
Closed -$226K 1476
2022
Q2
$226K Buy
+6,500
New +$232K ﹤0.01% 1375

Other funds holding AMPH

TD Asset Management's AMPH Position: Q2 2026 in Review

TD Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 1,541,044 shares — an estimated $30.2M sold.

TD Asset Management first reported a position in AMPH in Q2 2022 and held it in 14 quarters. The position peaked at $103M in Q3 2024. 159 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • TD Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • TD Asset Management sold 1,541,044 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $30.2M.
  • TD Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 14 quarters.
  • TD Asset Management's Amphastar Pharmaceuticals position peaked at $103M in Q3 2024.
  • 159 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.